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Introduction
The umbilical cord normally serves as the conduit for two 
umbilical arteries and one umbilical vein. Single umbilical ar-
tery (SUA) is characterized by absence of one of the umbilical 
arteries and its incidence occurs in 0.5% to 5% of pregnan-
cies  [1-3]. Till now, the mechanism of its development re-
mains uncertain. There are three widely accepted explanations 
concerning the pathogenesis of an absent umbilical artery: 
(1) primary agenesis of one umbilical artery; (2) secondary 
atrophy or atresia of a previously normal developed umbilical 
artery; and (3) persistence of the original allantoic artery of 
the body stalk. Embryological considerations, as well as the 
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Objective
The aim of this study was to evaluate the association between prenatally diagnosed isolated single umbilical artery 
(iSUA) and perinatal outcomes.
Methods
We searched Medline, Embase, the Cochrane Library, and KoreaMed from inception to January 2016, with no 
language or regional restrictions, for cohort and case-control studies reporting on the relationship of iSUA and 
perinatal outcomes. We assessed the odds ratios (ORs) and 95% confidence intervals (CIs) for the occurrence of small 
for gestational age, preterm birth, pregnancy-induced hypertension, neonatal intensive care unit admission, and 
perinatal mortality in fetuses with iSUA compared with those in fetuses with three vessel cord. 
Results
Eleven articles totaling 1,731 pregnancies with iSUA met the selection criteria. Studies varied in design, quality, 
outcome definition, and results. Meta-analysis carried out within predefined groups showed that the presence of an 
iSUA was associated with small for gestational age (OR, 2.75; 95% CI, 1.97 to 3.83; P<0.00001), preterm birth (OR, 2.10; 
95% CI, 1.72 to 2.57; P<0.00001), pregnancy-induced hypertension (OR, 1.62; 95% CI, 1.00 to 2.63; P=0.05), neonatal 
intensive care unit admission (OR, 2.06; 95% CI, 1.33 to 3.19; P=0.001), and perinatal mortality (OR, 2.29; 95% CI, 1.32 
to 3.98; P=0.003).
Conclusion
Pregnancies complicated by iSUA are at increased risk for small for gestational age, preterm birth, pregnancy-induced 
hypertension, neonatal intensive care unit admission and perinatal mortality. Further, large prospective cohort studies 
are required to improve the quality of prenatal counseling and the neonatal care for pregnancies with iSUA.
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detection of occluded remnants of a second umbilical artery 
in some SUA fetuses, suggest that the second theory is the 
most likely explanation [4-6]. 
Fetuses with a SUA are considered at increased risk of chro-
mosomal and structural abnormalities  [1,7-10]. Therefore, 
when SUA is diagnosed at the time of the mid-trimester 
scan, targeted ultrasound is warranted to rule out underly-
ing pathologic conditions. SUA is defined as an isolated SUA 
(iSUA), if it occurs with no congenital abnormality in fetal 
chromosomes or structure  [11]; In approximately 65% to 
80% of SUAs, it appears to be iSUAs. In pregnancies with an 
iSUA, variable outcomes of aneuploidy, small for gestational 
age (SGA), preterm birth, pregnancy-induced hypertension 
(PIH), neonatal intensive care unit (NICU) admission, and 
perinatal mortality have been reported when compared with 
those fetuses and neonates with three vessel cords (TVC) [11-
21]. However, a controversy exists concerning whether iSUA is 
associated with adverse perinatal outcomes, with other stud-
ies presenting different views. 
We carried out a comprehensive systematic review of the 
literature to evaluate the association of fetuses with prenatally 
diagnosed iSUA and perinatal outcomes.
Materials and methods
This systematic review was protocol driven using widely rec-
ommended methods for reviews and evaluation of causal as-
sociations. The review was carried out and has been reported 
according to the PRISMA (Preferred Reporting Items for Sys-
tematic review and Meta-Analysis) and MOOSE (Meta-analysis 
of Observational Studies in Epidemiology) guidelines.
1. Data sources and search strategy
We searched Medline, Embase, the Cochrane Library, and Ko-
reaMed, from inception until January 2016 for relevant pub-
lished articles. “Single umbilical artery,” “two vessel cord,” 
“two umbilical vessels,” “SUA,” “pregnancy outcome,” and 
“perinatal outcome” were entered as MeSH (Medical Subject 
Heading) terms and as keywords. The terms were then con-
nected through Boolean operators and the result was limited 
to studies reporting only on human subjects and clinical trials. 
We had no limitations on whether clinical trial was controlled 
or randomized, on language, or age group. We adapted the 
Medline search strategy for use in other databases. 
2. Eligibility criteria
Randomized controlled trials, cohort studies and case–control 
studies were considered eligible if they described iSUA identi-
fied by ultrasound before an average gestational age of 24 
completed weeks and perinatal outcomes. Studies were ex-
cluded if SUA was first diagnosed at birth or if the study was 
only on twin pregnancies. And we excluded studies with fifty 
or fewer cases, because of unreliability.
3. Study selection 
We selected studies for inclusion in a two-stage process. First, 
two independent reviewers (A and B) screened the titles and 
abstracts to identify eligible studies; Second, this screening was 
followed by retrieval and assessment of the full texts of the rel-
evant citations. When the same dataset was reported multiple 
times, we extracted data from the most recent study with the 
largest sample size for relevant outcomes. Any disagreements 
were resolved after discussion with a third reviewer (C).
4. Data extraction 
Data were extracted in duplicate (A and B) with predesigned 
data collection form. Study characteristics that were summa-
rized on the form included: first author, year of publication, 
data collection period, country of investigation and number 
of cases of iSUA and control groups. Quantitative data on the 
outcome variables included incidence of SGA, PIH, preterm 
labor, NICU admission and perinatal mortality. Dichotomous 
data were extracted as 2×2 tables of the association between 
the iSUA and the perinatal outcome. 
5. Study quality assessment 
We used the Newcastle-Ottawa Scale, which assigns points 
depending on the quality of patient selection (maximum 4 
stars), comparability of the cohort (maximum 2 stars), and 
outcome assessment (maximum 3 stars) to assess the meth-
odological quality of the included studies. Two independent 
reviewers (A and B) undertook quality assessment and allo-
cated stars. Studies that scored four stars for selection, two 
stars for comparability, and three stars for ascertainment of 
the outcome were regarded to have a low risk of bias. Studies 
with two or three stars for selection, one for comparability, 
and two for outcome ascertainment were deemed to have a 
medium risk of bias. Any study with a score of one for selec-
tion or outcome ascertainment, or zero for any of the three 
domains, was deemed to have a high risk of bias.
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6. Data synthesis and statistical analysis
Measures of effect used for dichotomous data are the odds 
ratio (OR). Methods used in this meta-analysis are specific to 
meta-analysis and include heterogeneity analysis, sensitivity 
analysis, and evaluation of publication bias. All methods used 
should allow for the weighting of studies. The concept of 
weighting reflects the value of the evidence of any particular 
study. Usually, studies are weighted according to the inverse 
of their variance. We tested the heterogeneity of results 
across the studies using the I2 test. If statistical heterogeneity 
was small (I2<50%) a Mantel-Haenszel fixed-effects model 
was used. For studies with moderate statistical heterogeneity 
(I2>50%), we used a Mantel-Haenszel random-effects model. 
We created funnel plots by plotting the natural logarithm of 
the ORs against the inverse of the standard error to assess 
publication and related bias. We statistically checked for the 
asymmetry of the funnel plot. We identified 11 studies and 
use software RevMan ver. 5.0 (The Cochrane Collaboration, 
Oxford, UK) to estimate effects size.
Results
1. Study characteristics and quality assessment 
An initial search of 4,706 citations identified from the four 
databases. Of the 109 eligible articles, we selected 57 studies 
for detailed assessment. Of these, 46 studies did not meet 
the inclusion criteria, leaving 11 studies for inclusion in the 
systematic review. The selection process of the studies and 
reasons for exclusion are shown in Fig. 1. Table 1 shows the 
characteristics of the 11 included studies [11-21]. The studies 
comprised 3 case-control studies and 8 cohort studies. These 
studies reported iSUA cases between 68 and 392, resulting in 
a total number of cases with an iSUA of 1,731. Quality assess-
ment by the Newcastle-Ottawa Scale  showed that all of the 
included studies had medium risk of bias. One of the 11 stud-
ies had low risk of bias for study selection, 10 had medium 
risk of bias. For comparability of the cohorts, all of the studies 
had low risk of bias. The risk of bias for outcome assessment 
was low in 6 studies, medium in 5 studies.
2. SGA
Eleven studies (8 cohort studies and 3 case-control studies) 
totaling 1,731 fetuses with iSUA reported on the association 
between SGA and iSUA. All studies had an OR point estimate 
greater than 1.0 and OR was 2.75, implying that the inci-
dence of SGA in fetuses with iSUA was significantly higher 
than in fetuses with TVC, and iSUA increased the risk of SGA. 
Heterogeneity was significant (I2=71%) overall (Fig. 2) [11-21]. 
3. Preterm birth 
For preterm birth, 5 studies totaling 127,742 pregnancies 
examined the association between iSUA and preterm birth. 
However, these studies did not differentiate between medical-
ly indicated and spontaneous preterm deliveries. No heteroge-
neity was found (chi2=3.09, P=0.66, I2=3%), we chose fixed-
effects model to do the meta-analysis. 4 studies had an OR 
Fig. 1. Flow chart of filtering for literature search. SUA, single um-
bilical artery.
4,706 Total records reviewed
 1,723 Medline
 2,979 Embase
 0 The cochrane library
 4 KoreaMed
109 Records screened for eligibility
57 Full-text articles assessed for eligibility
11 Studies included in qualitative synthesis
11 Studies included in quantitive synthesis
4,597 Excluded
 2,726 Article not on SUA, irrelevant
 1,836 Duplicates
52 Records excluded based on title or abstract
 4 Abstract
 13 Review/opinion article
 5 In-vitro studies, on basic medicine
 2 Animal study
 21 Case reports
 7 Case series
46 Records excluded based on full-text
 33 Article not on islated SUA
 5 Only twin gestations studied
 8 No prenatal diagnosis
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point estimate greater than 1.0. The overall association was 
OR 2.10 (95% CI, 1.72 to 2.57; P<0.00001). These results sug-
gest that the incidence of preterm birth in fetuses with iSUA 
was significantly higher than in fetuses with TVC, and iSUA 
increased the risk of any preterm birth (Fig. 3) [11,13,17,18,20]
4. PIH
The association between PIH and iSUA were assessed in 7 
studies. Significant heterogeneity was found (chi2 = 17.18, 
P = 0.009, I2 = 65%) (Fig. 4) [11-13,17-20], so random-effect 
model was used. The association between PIH and iSUA were 
seen in all meta-analyses. The reported ORs in the 7 individual 
studies ranged from 0.72 to 5.25 and OR was 1.62 (95% CI, 
1.00 to 2.63; P=0.05), indicating that the incidence of PIH in 
fetuses with iSUA was significantly higher than that in fetuses 
with TVC and iSUA was associated with the occurrence of PIH.
5. NICU admission
When we pooled the data from the 2 case-control studies 
and 4 cohort studies, we found a statistically significant as-
sociation between iSUA and admission to the NICU (OR, 2.06; 
95% confidence interval [CI], 1.33 to 3.19; P=0.001) (Fig. 5) 
[12-14,16,18,20]. 
6. Perinatal mortality
For perinatal mortality, estimates were reported from 5 retro-
Table 1. Characteristics of studies in the meta-analysis 
Author Year Country Study design Follow up SUA TVC
Gornall [15] 2003 UK Cohort retrospective 1995–2001 107 214
Predanic [21] 2005 USA Case control 1999–2004 84 84
Bombrys [14] 2008 USA Cohort retrospective 2000–2006 255 289
Horton [16] 2010 USA Case control 2000–2008 68 68
Hua [17] 2010 USA Cohort retrospective 1990–2007 392 63,655
Khalil [18] 2013 Saudi Arabia Cohort retrospective 2004–2012 159 35,026
Mailath-Pokorny [19] 2015 Austria Cohort retrospective 2004–2011 136 500
Ashwal [12] 2014 Israel Case control 2008–2012 91 182
Battarbee [13] 2015 USA Cohort retrospective 2007–2014 219 219
Naveiro-Fuentes [20] 2016 Spain Cohort retrospective 2007–2014 127 27,752
Tülek [11] 2015 Turkey Cohort retrospective 2006–2013 93 100
Only first author of each study is given. 
SUA, single umbilical artery; TVC, three vessel cord.
Fig. 2. Forest plot of odds ratio with 95% confidence interval (CI) for small for gestational age in fetuses with isolated single umbilical 
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spective cohort studies and one case-control study with 1,176 
iSUA cases. No heterogeneity was found (chi2 =2.40, P = 0.66, 
I2 = 0%), we chose fixed-effect model to do the meta-analysis. 
This meta-analysis showed that perinatal mortality is signifi-
cantly associated with iSUA (OR, 2.29; 95% CI, 1.32 to 3.98; 
P=0.003) (Fig. 6) [13-18]. 
Fig. 3. Forest plot of odds ratio with 95% confidence interval (CI) for preterm birth in fetuses with isolated single umbilical artery (SUA) 
compared with fetuses with three vessel cord (TVC). M-H, Mantel-Haenszel test.
Fig. 4. Forest plot of odds ratio with 95% confidence interval (CI) for pregnancy-induced hypertension in fetuses with isolated single um-
bilical artery (SUA) compared with fetuses with three vessel cord (TVC). M-H, Mantel-Haenszel test.
Fig. 5. Forest plot of odds ratio with 95% confidence interval (CI) for neonatal intensive care unit admission in fetuses with isolated 




















Hyeong Ju Kim, et al. Single umbilical artery and outcomes 
Discussion
This study performed a meta-analysis of 11 studies that con-
sidered the relationship between prenatally diagnosed iSUA 
and perinatal outcomes, including SGA, preterm birth, PIH, 
and perinatal mortality. There has been controversy regarding 
the association between iSUA and fetal growth. Tulek et al. 
[11] analyzed birth weight and found that SGA was three-fold 
as likely in pregnancies with iSUA compared to pregnancies 
with TVC. Other recent studies also reported similar results 
[13,17-20]. However, Bombrys et al. [14] found that iSUA was 
not associated with a higher rate of SGA in comparison with 
newborns with TVC (13.7% vs. 13.9%, P=0.93). Horton et 
al. [16] reported that even though the ponderal index, which 
is a more accurate measure of neonatal slenderness, was 
significantly lower in neonates with iSUA compared with TVC 
neonates (24.2±1.1 vs. 26.1±1.3 g/cm3, P=0.001), there was 
no significant difference in rates of SGA (17.6% vs. 8.8%, 
P=0.06).
The association between preterm birth and iSUA is also con-
troversial. Some studies have shown a higher risk of preterm 
birth in cases with iSUA [13,20] and others have demonstrat-
ed no association [11]. Hua et al. [17] did not find a higher 
rate of preterm birth when comparing newborns with iSUA 
with those with normal umbilical cord. Murphy-Kaulbeck et 
al. [22] demonstrated that rates of prematurity were signifi-
cantly higher for less than 37 weeks of gestation (OR, 2.48; 
95% CI, 1.91 to 3.23).
The relationship between iSUA and perinatal mortality also 
remains controversial. In the study conducted by Bombrys et 
al. [14], the finding of iSUA was not associated with increased 
perinatal morbidity or mortality. Burshtein et al. [23] reported 
iSUA as an independent risk factor for perinatal mortality (OR, 
7.78; 95% CI, 4.68 to 12.95).
It has been hypothesized that the high incidence of SGA, 
NICU admission, and perinatal mortality in fetuses with 
iSUA may occur secondary to a relatively high prevalence of 
preterm birth [11-15]. But it is not clear why the incidence 
of gestational hypertension and preeclampsia is higher for 
fetuses that have a single umbilical artery but appear to be 
structurally normal. One hypothesis is that fetuses with single 
umbilical arteries are at greater risk of anomalous cord devel-
opment, as part of a wider pathological process affecting the 
placenta and perfusion rather than inadequate fetoplacental 
blood flow through the remaining umbilical artery [15]. Hau-
gen et al. [24] reported further evidence in support of this 
hypothesis by showing that SUA displayed markedly higher 
outflow levels of prostacyclin, endothelium-derived relaxing 
factor. Moreover, the vasoactive intestinal peptide that induc-
es dose-dependent relaxation is able to increase the prostacy-
clin formation in the two umbilical arteries rather than in the 
SUA [24-26].
The first systematic review and meta-analysis on the as-
sociation between the presence of an iSUA and perinatal 
outcomes was published in 2013, and reported that there 
was no statistically significant difference in perinatal mortality 
between fetuses with an iSUA and TVC [27]. As stated in that 
meta-analysis, this non-significant result might be due to the 
limited sample size; the study included only 7 eligible papers 
covering 928 cases with iSUA. In contrast, our meta-analysis 
included 11 eligible studies covering 1,731 pregnancies with 
iSUA. 
In our meta-analysis, there were statistically significant dif-
ferences in the incidence of SGA, preterm birth, PIH, and 
Fig. 6. Forest plot of odds ratio with 95% confidence interval (CI) for perinatal mortality in fetuses with isolated single umbilical artery (SUA) 
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perinatal mortality between iSUA and TVC fetuses, implying 
that the incidence of these complications was correlated with 
iSUA, and that iSUA may increase the risk of these complica-
tions.
This meta-analysis provides the best currently available 
evidence of an association between iSUA and perinatal out-
comes. This review provides much needed information about 
iSUA and perinatal outcomes and will help in the counselling 
of women with a fetus with iSUA. To our knowledge, this re-
view is the most comprehensive meta-analysis evaluating the 
association of iSUA and perinatal outcomes. We performed an 
extensive literature search without language restrictions, there-
by increasing the likelihood of retrieving all relevant studies.
This review has several limitations. The main weakness of 
these studies was the retrospective design and the fact that 
most of the outcomes were explored by a limited number of 
studies, despite our efforts to identify all relevant literature. 
Although the quality assessment of the studies was gener-
ally high, the heterogeneity was significant for all outcomes 
analyzed. Since large or extreme heterogeneity may lead to a 
misleading conclusion, the degree of heterogeneity is one of 
the main concerns in meta-analysis. In this study, significant 
heterogeneity was present in the overall analysis.
Our meta-analysis has provided a systematic review of the 
association between the presence of an iSUA and various 
perinatal outcomes. Our results suggest that iSUA is associ-
ated with a significant increase in adverse perinatal outcomes 
such as SGA, preterm birth, PIH, admission to the NICU, and 
perinatal mortality.
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